苯磺酸氨氯地平联合贝那普利治疗老年高血压的可行性分析  被引量:2

Feasibility analysis of amlodipine besylate combined with benner pury in the treatment of elderly patients with hypertension

在线阅读下载全文

作  者:王晓霞 张科[2] Wang Xiaoxia;Zhang Ke(Meili Community Health Service Center of Changshou City,Jiangsu Province 215500;Department of Gastroenterology,the Second People's Hospital of Changshou City,Jiangsu Province)

机构地区:[1]江苏省常熟市梅李社区卫生服务中心,215500 [2]江苏省常熟市第二人民医院消化内科,215500

出  处:《中国社区医师》2018年第21期64-64,66,共2页Chinese Community Doctors

摘  要:目的:研究苯磺酸氨氯地平与贝那普利联合疗法在老年高血压中的应用价值。方法:收治老年高血压患者72例,随机平分为两组。均常规应用苯磺酸氨氯地平,A组加用盐酸贝那普利。综合分析两组血压的变化情况,并对各组的临床疗效作出分析比较。结果:A组治疗后的舒张压和收缩压明显比B组低,组间差异有统计学意义(P<0.05)。A组的临床总有效率97.22%,明显比B组的83.33%高,组间差异有统计学意义(P<0.05)。结论:联合应用苯磺酸氨氯地平与贝那普利对老年高血压患者进行施治,可有效促进其血压降低,提高病情控制效果。Objective:To study the value of amlodipine besylate combined with benner pury in the treatment of elderly patients with hypertension.Methods:72 elderly patients with hypertension were selected.They were randomly divided into the two groups on average.Amlodipine besylate was routinely used.The group A added benazeprine hydrochloride treatment.The changes of blood pressure in the two groups were analyzed,and the clinical efficacy of each group was analyzed and compared.Results:The diastolic pressure and systolic pressure in the group A were significantly lower than those in the group B,and the difference between groups was statistically significant(P<0.05).The total effective rate of the group A was 97.22%,significantly higher than that of the group B of 83.33%,and the difference between groups was statistically significant(P<0.05).Conclusion:Combined application of amlodipine besylate and benner pury in the treatment of elderly patients with hypertension can effectively promote their blood pressure reduction and improve the effect of disease control.

关 键 词:苯磺酸氨氯地平 可行性 老年高血压 贝那普利 

分 类 号:R544.1[医药卫生—心血管疾病]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象